About: Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2008

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2008 (uk) artículu científicu espublizáu n'agostu de 2008 (ast) scientific article published on 01 August 2008 (en)
publication date	wds:Q81774016-CDF9713F-F380-4261-A3A1-AC6DBA98F216
publication date	2008-08-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q81774016-30893378-4A85-4ABA-ACA4-BCB8BA12B40A wds:Q81774016-4B2E1F6D-DC10-4297-B58F-AADB84CF767A wds:Q81774016-540E5D97-E60A-47DB-8B3C-0E56A484448A wds:Q81774016-6C79CEA2-54D7-42E5-B017-2A256044AE12 wds:Q81774016-7C4BD125-C80A-4AF8-956D-2BB4A9E591D2
author name string	Magnus Persson Lill-Tove Busund Roy M Bremnes Tom Donnem Khalid I Al-Shibli
rdfs:label	Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer (en) Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer (nl)
skos:prefLabel	Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer (en) Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer (nl)
name	Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer (en) Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer (nl)
author	wds:Q81774016-92D7FB4D-EC80-4D76-A212-A94B560DA3E7
author	Samer Al-Saad
title	wds:Q81774016-844AACF8-00F0-4A9A-BA85-BEDC07EADFBA
title	Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer (en)
page(s)	wds:Q81774016-020FAF8F-6A26-421D-9CBF-03CF10A65538
page(s)	5220-5227
instance of	wds:Q81774016-B0BE9B22-14C4-4AE7-A5E7-63E8AE4F1358
instance of	scholarly article
main subject	wds:Q81774016-5AB55354-1A4A-49D9-AD66-2BF5F62544BD
main subject	non-small-cell lung carcinoma
PubMed ID	wds:Q81774016-DA152ACD-07D2-4036-86E4-2A6D1161A8FF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18698040
PubMed ID	18698040
published in	wds:Q81774016-4CF357A3-9684-44EA-A12B-B7D1ED147FED
published in	Clinical Cancer Research
issue	wds:Q81774016-EA63056E-A666-4261-9725-1C5C9C32A6B7
volume	wds:Q81774016-2FD25C62-28C9-4622-BFC7-ACF30B301DB9
issue	16
volume	14
DOI	wds:Q81774016-389D4D82-557A-4648-BC69-7DA6813435BB
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-08-0133
DOI	10.1158/1078-0432.CCR-08-0133
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81774016
is cites work of	The immune contexture in human tumours: impact on clinical outcome Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival In situ vaccination combined with androgen ablation and regulatory T-cell depletion reduces castration-resistant tumor burden in prostate-specific pten knockout mice High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention The impact of the immune system on tumor: angiogenesis and vascular remodeling Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma Primary extraosseous Ewing sarcoma of the lung in children Tumor infiltrating B-cells are increased in prostate cancer tissue The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis Immune infiltration in human tumors: a prognostic factor that should not be ignored Prognostic impact of lymphocytes in soft tissue sarcomas Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directions Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers Does the immune system naturally protect against cancer? Immune reconstitution from peripheral blood mononuclear cells inhibits lung carcinoma growth in NOD/SCID mice Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer Trial watch: Prognostic and predictive value of the immune infiltrate in cancer Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer Characteristics of tertiary lymphoid structures in primary cancers Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. Prognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma: Tumor-Infiltrating CD10+ Neutrophil/CD20+ Lymphocyte Ratio as an Independent Prognostic Factor Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients. The tumor microenvironment: a pitch for multiple players. Heterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer Objective measurement and clinical significance of TILs in non-small cell lung cancer CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer. Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status Dual Functional Capability of Dendritic Cells - Cytokine-Induced Killer Cells in Improving Side Effects of Colorectal Cancer Therapy New modalities of cancer treatment for NSCLC: focus on immunotherapy The immunological effect of hyaluronan in tumor angiogenesis The prognostic influence of tumor infiltrating Foxp3(+)CD4(+), CD4(+) and CD8(+) T cells in resected non-small cell lung cancer Cancer stem cells in small cell lung cancer Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy Clinical evaluation of systemic and local immune responses in cancer: time for integration Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy What lies within: novel strategies in immunotherapy for non-small cell lung cancer Vaccines against human carcinomas: strategies to improve antitumor immune responses Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer Tumor-induced CD8+ T-cell dysfunction in lung cancer patients. The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity B cells promote tumor progression via STAT3 regulated-angiogenesis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software